The Nipro Group has significantly expanded its contract manufacturing capabilities for oral dosage forms and injection drugs and TTS by setting up new group companies and expanding production equipment. With regard to oral dosage forms, we are currently preparing manufacturing facilities for 10 billion tablets. We have also realized further expansion of all types of contracting capabilities in injection drugs too. Including TTS, for which we promote contract services positively, we also promote contract services for manufacturing investigational new drugs in various fields, APIs and components for pharmaceutical primary packages.